BackCosmo Pharmaceuticals N.V. Overview

Cosmo Pharmaceuticals N.V. Current Cash

Track Cosmo Pharmaceuticals N.V.'s current cash ($31M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$30.87M
↓ 39.17% YoYΔ $-19.88M vs prior year quarter

Peer trimmed avg / median

Loading

Cosmo Pharmaceuticals N.V. Current Cash History

Loading

Cosmo Pharmaceuticals N.V. vs. peers: Current Cash Comparison

Loading

Cosmo Pharmaceuticals N.V. Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cosmo Pharmaceuticals N.V. (CMOPF) FAQ

Cosmo Pharmaceuticals N.V. posts a current cash of $31M as of June 2026. That compares with $51M in the prior-year period — down 39.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Cosmo Pharmaceuticals N.V.'s current cash was $51M. The latest reading is $31M — a 39.2% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Cosmo Pharmaceuticals N.V.'s financial statement story. At $31M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CMOPF's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Cosmo Pharmaceuticals N.V.'s other metric pages and overview cover the third.